Teva Pharmaceuticals USA Inc

Complete recall history across all FDA and CPSC categories — 20 total recalls

Teva Pharmaceuticals USA Inc appears in recall records across 1 category. This page consolidates all FDA food, drug, and medical device enforcement actions, plus CPSC consumer product recalls associated with this company. Recall data is sourced from openFDA and CPSC public databases.

Drug Recalls (20)

FDA drug safety enforcement actions by Teva Pharmaceuticals USA Inc

Date Product Reason Class
Jul 5, 2023 Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured B... Failed Moisture Limits: Water (moisture) content above the approved product s... Class II
Apr 27, 2023 Fentanyl Buccal Tablets CII, 100mcg, packaged in cartons of 28 Buccal Tablets... Labeling: Incorrect or Missing Package Insert Class III
Apr 27, 2023 Fentanyl Buccal Tablets CII, 800mcg, packaged in cartons of 28 Buccal Tablets... Labeling: Incorrect or Missing Package Insert Class III
Apr 27, 2023 Fentanyl Buccal Tablets CII, 200mcg, packaged in cartons of 28 Buccal Tablets... Labeling: Incorrect or Missing Package Insert Class III
Apr 27, 2023 Fentanyl Buccal Tablets CII, 400mcg, packaged in cartons of 28 Buccal Tablets... Labeling: Incorrect or Missing Package Insert Class III
Apr 27, 2023 Fentanyl Buccal Tablets CII, 600mcg, packaged in cartons of 28 Buccal Tablets... Labeling: Incorrect or Missing Package Insert Class III
Mar 27, 2023 Montelukast Sodium Oral Granules USP, 4 mg, packaged in a carton containing 3... Failed Impurities/Degradation Specifications: failed impurities for Sulphoxid... Class III
Feb 23, 2023 Clear Eyes, Once Daily, Eye Allergy Itch Relief, olopatadine hydrochloride op... Failed Impurities Specification: Out-of-specification (OOS) stability test re... Class II
Feb 22, 2023 Metformin hydrochloride Extended-Release Tablets, 1000 mg, 60-count bottle, R... CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess ... Class II
Aug 29, 2022 Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfat... Labeling: Label Error on Declared Strength; A sealed 100-count bottle labeled... Class II
Aug 23, 2022 Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distribute... CGMP Deviations: A foreign matter identified as teflon was found in the Activ... Class II
Jul 22, 2022 Azacitidine for Injection 100mg/vial Lyophilized Powder, Rx Only, Mfd. in Rom... Subpotent Drug - Out of specification (OOS) result obtained during monitoring... Class III
Jul 21, 2022 Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 180 mg, 30-coun... Failed Dissolution Specifications: below specification limits for dissolution. Class II
Jul 21, 2022 Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30-coun... Failed Dissolution Specifications: below specification limits for dissolution. Class II
Jun 29, 2022 Testosterone Gel 1% (25mg testosterone/2.5g of gel) 2.5 g per unit dose, Rx O... Superpotent Drug: Out of specification assay result was obtained during stabi... Class II
Jun 14, 2022 Tretinoin Capsules, 10 mg, Rx Only, 100 capsules per bottle, Teva Pharmaceuti... Failed Dissolution Specifications; Low Out of Specification (OOS) results for... Class II
May 18, 2022 Alprostadil Injection USP 500 mcg/mL, 1 mL Single Dose Vial, 5 vials per Cart... Failed Impurities/Degradation Specifications; out-of-specification results fo... Class III
May 11, 2022 Anagrelide Capsules USP, 0.5 mg, 100-count bottles, Rx Only, Manufactured in... Failed Dissolution Specifications- Low Out-Of-Specification results obtained ... Class I
Apr 15, 2022 Lidocaine 2.5% and Prilocaine 2.5% Cream, USP, packaged in a) 5 g tubes (NDC... cGMP Deviations Class II
Mar 29, 2022 IDArubicin Hydrochloride Injection USP 5gm/5mL (1mg/mL) for intravenous use, ... Presence of Particulate Matter: Product was found to contain silica and iron ... Class I

Frequently Asked Questions

A high number of recalls does not necessarily indicate that a company is unsafe. Large manufacturers that produce thousands of products across multiple categories will statistically appear in recall databases more frequently. What matters more is the severity of each recall (Class I being the most serious), the speed of response, and whether the company proactively identified and addressed the issue. Companies with robust safety programs often catch problems earlier.

Food, drug, and medical device recall data comes from the FDA's openFDA enforcement database, which contains all FDA enforcement reports. Consumer product recall data comes from the U.S. Consumer Product Safety Commission (CPSC). Both sources are public government databases that are updated regularly. RecallCheck aggregates these sources to provide a unified view of a company's recall history.

The FDA classifies recalls into three categories. Class I is the most serious — there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. Class II means the product may cause temporary or medically reversible health problems, or the probability of serious consequences is remote. Class III is the least serious — the product is unlikely to cause adverse health consequences. CPSC product recalls do not use this classification system.

Yes. You can search for any company using the firm/manufacturer pages for each category: Food Firms, Drug Firms, Device Firms, or Product Manufacturers. You can also use the search functionality on any browse page to find recalls by company name.

Explore More Recalls

Search recalls by category, state, reason, or firm across all our databases.